2023-2029 Global 3D Printing Pharmaceuticals Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for 3D Printing Pharmaceuticals should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China 3D Printing Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States 3D Printing Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, FDM segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Personalized Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of 3D Printing Pharmaceuticals include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
This report aims to provide a comprehensive study of the global market for 3D Printing Pharmaceuticals. Report Highlights:
(1) Global 3D Printing Pharmaceuticals market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global 3D Printing Pharmaceuticals market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China 3D Printing Pharmaceuticals market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global 3D Printing Pharmaceuticals segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global 3D Printing Pharmaceuticals segment by type and by application and regional segment by type and by application.
(6) Global major production regions of 3D Printing Pharmaceuticals, capacity, production and trends.
(7) 3D Printing Pharmaceuticals industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
FDM
SLS
PB
SLA
SSE
DPE
DOD
MDD
MED
Market segment by application, can be divided into
Personalized Pharmacy
Nutrients
Market segment by players, this report covers
Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics
1 Market Overview
1.1 3D Printing Pharmaceuticals Definition
1.2 Global 3D Printing Pharmaceuticals Market Size and Forecast
1.2.1 By Revenue, Global 3D Printing Pharmaceuticals Market Size, 2018-2029
1.2.2 By Sales Volume, Global 3D Printing Pharmaceuticals Market Size, 2018-2029
1.2.3 Global 3D Printing Pharmaceuticals Price Trend, 2018-2029
1.3 China 3D Printing Pharmaceuticals Market Size and Forecast
1.3.1 By Revenue, China 3D Printing Pharmaceuticals Market Size, 2018-2029
1.3.2 By Sales Volume, China 3D Printing Pharmaceuticals Market Size, 2018-2029
1.3.3 China 3D Printing Pharmaceuticals Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China 3D Printing Pharmaceuticals Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China 3D Printing Pharmaceuticals Share in Global Market, 2018-2029
1.4.3 3D Printing Pharmaceuticals Market Size: China VS Global, 2018-2029
1.5 3D Printing Pharmaceuticals Market Dynamics
1.5.1 3D Printing Pharmaceuticals Market Drivers
1.5.2 3D Printing Pharmaceuticals Market Restraints
1.5.3 3D Printing Pharmaceuticals Industry Trends
1.5.4 3D Printing Pharmaceuticals Industry Policy
2 Global Competitive Landscape by Company
2.1 Global 3D Printing Pharmaceuticals Revenue by Company, 2018-2023
2.2 Global 3D Printing Pharmaceuticals Sales Volume by Company, 2018-2023
2.3 Global 3D Printing Pharmaceuticals Price by Company, 2018-2023
2.4 Global 3D Printing Pharmaceuticals Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global 3D Printing Pharmaceuticals Concentration Ratio
2.6 Global 3D Printing Pharmaceuticals Mergers & Acquisitions, Expansion Plans
2.7 Global 3D Printing Pharmaceuticals Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China 3D Printing Pharmaceuticals Revenue by Company, 2018-2023
3.2 China 3D Printing Pharmaceuticals Sales Volume by Company, 2018-2023
3.3 China 3D Printing Pharmaceuticals 3D Printing Pharmaceuticals Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China 3D Printing Pharmaceuticals Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, 3D Printing Pharmaceuticals Domestic VS Export
3.6 China Market, 3D Printing Pharmaceuticals Import & Export
3.6.1 China Market, 3D Printing Pharmaceuticals Import & Export, 2018-2029
3.6.2 China 3D Printing Pharmaceuticals Import & Export Trends
3.6.3 Main Sources of China 3D Printing Pharmaceuticals Import
3.6.4 Export Destination of China 3D Printing Pharmaceuticals
4 3D Printing Pharmaceuticals Production by Region
4.1 Global 3D Printing Pharmaceuticals Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of 3D Printing Pharmaceuticals Manufacturers
4.3 Global Major Manufacturers, 3D Printing Pharmaceuticals Capacity Expansion and Future Plans
4.4 Global 3D Printing Pharmaceuticals Capacity by Region
4.5 Global 3D Printing Pharmaceuticals Production by Region
4.5.1 Global 3D Printing Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global 3D Printing Pharmaceuticals Production by Region, 2018-2023
4.5.3 Global 3D Printing Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 3D Printing Pharmaceuticals Industry Chain
5.2 3D Printing Pharmaceuticals Upstream Analysis
5.2.1 3D Printing Pharmaceuticals Core Raw Materials
5.2.2 Main Manufacturers of 3D Printing Pharmaceuticals Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 3D Printing Pharmaceuticals Production Mode
5.6 3D Printing Pharmaceuticals Procurement Model
5.7 3D Printing Pharmaceuticals Industry Sales Model and Sales Channels
5.7.1 3D Printing Pharmaceuticals Sales Model
5.7.2 3D Printing Pharmaceuticals Typical Distributors
6 Sights by Type
6.1 3D Printing Pharmaceuticals Classification
6.1.1 FDM
6.1.2 SLS
6.1.3 PB
6.1.4 SLA
6.1.5 SSE
6.1.6 DPE
6.1.7 DOD
6.1.8 MDD
6.1.9 MED
6.2 By Type, Global 3D Printing Pharmaceuticals Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global 3D Printing Pharmaceuticals Revenue, 2018-2029
6.4 By Type, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029
6.5 By Type, Global 3D Printing Pharmaceuticals Price, 2018-2029
7 Sights by Application
7.1 3D Printing Pharmaceuticals Segment by Application
7.1.1 Personalized Pharmacy
7.1.2 Nutrients
7.2 By Application, Global 3D Printing Pharmaceuticals Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global 3D Printing Pharmaceuticals Revenue, 2018-2029
7.4 By Application, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029
7.5 By Application, Global 3D Printing Pharmaceuticals Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global 3D Printing Pharmaceuticals Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global 3D Printing Pharmaceuticals Revenue, 2018-2029
8.3 By Region, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029
8.4 North America
8.4.1 North America 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America 3D Printing Pharmaceuticals Market Size Market Share
8.5 Europe
8.5.1 Europe 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe 3D Printing Pharmaceuticals Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific 3D Printing Pharmaceuticals Market Size Market Share
8.7 South America
8.7.1 South America 3D Printing Pharmaceuticals Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America 3D Printing Pharmaceuticals Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global 3D Printing Pharmaceuticals Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global 3D Printing Pharmaceuticals Revenue, 2018-2029
9.3 By Country, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. 3D Printing Pharmaceuticals Market Size, 2018-2029
9.4.2 By Company, U.S. 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.4.3 By Type, U.S. 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe 3D Printing Pharmaceuticals Market Size, 2018-2029
9.5.2 By Company, Europe 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.5.3 By Type, Europe 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China 3D Printing Pharmaceuticals Market Size, 2018-2029
9.6.2 By Company, China 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.6.3 By Type, China 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.6.4 By Application, China 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan 3D Printing Pharmaceuticals Market Size, 2018-2029
9.7.2 By Company, Japan 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.7.3 By Type, Japan 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea 3D Printing Pharmaceuticals Market Size, 2018-2029
9.8.2 By Company, South Korea 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.8.3 By Type, South Korea 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia 3D Printing Pharmaceuticals Market Size, 2018-2029
9.9.2 By Company, Southeast Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India 3D Printing Pharmaceuticals Market Size, 2018-2029
9.10.2 By Company, India 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.10.3 By Type, India 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.10.4 By Application, India 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia 3D Printing Pharmaceuticals Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia 3D Printing Pharmaceuticals Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Triastek,Inc.
10.1.1 Triastek,Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Triastek,Inc. 3D Printing Pharmaceuticals Models, Specifications and Application
10.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Triastek,Inc. Company Profile and Main Business
10.1.5 Triastek,Inc. Recent Developments
10.2 Aprecia
10.2.1 Aprecia Company Information, Head Office, Market Area and Industry Position
10.2.2 Aprecia 3D Printing Pharmaceuticals Models, Specifications and Application
10.2.3 Aprecia 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Aprecia Company Profile and Main Business
10.2.5 Aprecia Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.3.2 AstraZeneca 3D Printing Pharmaceuticals Models, Specifications and Application
10.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AstraZeneca Company Profile and Main Business
10.3.5 AstraZeneca Recent Developments
10.4 FabRx
10.4.1 FabRx Company Information, Head Office, Market Area and Industry Position
10.4.2 FabRx 3D Printing Pharmaceuticals Models, Specifications and Application
10.4.3 FabRx 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 FabRx Company Profile and Main Business
10.4.5 FabRx Recent Developments
10.5 Multiply Labs
10.5.1 Multiply Labs Company Information, Head Office, Market Area and Industry Position
10.5.2 Multiply Labs 3D Printing Pharmaceuticals Models, Specifications and Application
10.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Multiply Labs Company Profile and Main Business
10.5.5 Multiply Labs Recent Developments
10.6 DiHeSys
10.6.1 DiHeSys Company Information, Head Office, Market Area and Industry Position
10.6.2 DiHeSys 3D Printing Pharmaceuticals Models, Specifications and Application
10.6.3 DiHeSys 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 DiHeSys Company Profile and Main Business
10.6.5 DiHeSys Recent Developments
10.7 Merck
10.7.1 Merck Company Information, Head Office, Market Area and Industry Position
10.7.2 Merck 3D Printing Pharmaceuticals Models, Specifications and Application
10.7.3 Merck 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Merck Company Profile and Main Business
10.7.5 Merck Recent Developments
10.8 Merck KGaA
10.8.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
10.8.2 Merck KGaA 3D Printing Pharmaceuticals Models, Specifications and Application
10.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Merck KGaA Company Profile and Main Business
10.8.5 Merck KGaA Recent Developments
10.9 TNO
10.9.1 TNO Company Information, Head Office, Market Area and Industry Position
10.9.2 TNO 3D Printing Pharmaceuticals Models, Specifications and Application
10.9.3 TNO 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 TNO Company Profile and Main Business
10.9.5 TNO Recent Developments
10.10 Therics
10.10.1 Therics Company Information, Head Office, Market Area and Industry Position
10.10.2 Therics 3D Printing Pharmaceuticals Models, Specifications and Application
10.10.3 Therics 3D Printing Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Therics Company Profile and Main Business
10.10.5 Therics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. 3D Printing Pharmaceuticals Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. 3D Printing Pharmaceuticals Market Restraints
Table 3. 3D Printing Pharmaceuticals Market Trends
Table 4. 3D Printing Pharmaceuticals Industry Policy
Table 5. Global 3D Printing Pharmaceuticals Revenue by Company, 2018-2023, US$ million
Table 6. Global 3D Printing Pharmaceuticals Revenue Market Share by Company, 2018-2023
Table 7. Global 3D Printing Pharmaceuticals Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global 3D Printing Pharmaceuticals Sales Volume Market Share by Company, 2018-2023
Table 9. Global 3D Printing Pharmaceuticals Price by Company, 2018-2023, (US$/Unit)
Table 10. Global 3D Printing Pharmaceuticals Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global 3D Printing Pharmaceuticals Mergers & Acquisitions, Expansion Plans
Table 12. Global 3D Printing Pharmaceuticals Manufacturers Product Type
Table 13. China 3D Printing Pharmaceuticals Revenue by Company, 2018-2023, US$ million
Table 14. China 3D Printing Pharmaceuticals Revenue Market Share by Company, 2018-2023
Table 15. China 3D Printing Pharmaceuticals Sales Volume by Company, 2018-2023, (K Units)
Table 16. China 3D Printing Pharmaceuticals Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, 3D Printing Pharmaceuticals Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China 3D Printing Pharmaceuticals Import & Export Trends
Table 19. Main Sources of China 3D Printing Pharmaceuticals Import
Table 20. Export Destination of China 3D Printing Pharmaceuticals
Table 21. Global Headquarters and Manufacturing Base of 3D Printing Pharmaceuticals Manufacturers
Table 22. Global Major Manufacturers, 3D Printing Pharmaceuticals Capacity Expansion and Future Plans
Table 23. Global 3D Printing Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global 3D Printing Pharmaceuticals Production by Region, 2018-2023, (K Units)
Table 25. Global 3D Printing Pharmaceuticals Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of 3D Printing Pharmaceuticals Upstream (Raw Materials)
Table 27. Global 3D Printing Pharmaceuticals Typical Customers
Table 28. 3D Printing Pharmaceuticals Typical Distributors
Table 29. By Type, Global 3D Printing Pharmaceuticals Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global 3D Printing Pharmaceuticals Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global 3D Printing Pharmaceuticals Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global 3D Printing Pharmaceuticals Revenue, 2018-2029, US$ Million
Table 33. By Region, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global 3D Printing Pharmaceuticals Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global 3D Printing Pharmaceuticals Revenue, 2018-2029, US$ Million
Table 36. By Country, Global 3D Printing Pharmaceuticals Revenue Market Share, 2018-2029
Table 37. By Country, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global 3D Printing Pharmaceuticals Sales Volume Market Share, 2018-2029
Table 39. Triastek,Inc. Company Information, Head Office, Market Area and Industry Position
Table 40. Triastek,Inc. 3D Printing Pharmaceuticals Models, Specifications and Application
Table 41. Triastek,Inc. 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Triastek,Inc. Company Profile and Main Business
Table 43. Triastek,Inc. Recent Developments
Table 44. Aprecia Company Information, Head Office, Market Area and Industry Position
Table 45. Aprecia 3D Printing Pharmaceuticals Models, Specifications and Application
Table 46. Aprecia 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Aprecia Company Profile and Main Business
Table 48. Aprecia Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 50. AstraZeneca 3D Printing Pharmaceuticals Models, Specifications and Application
Table 51. AstraZeneca 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. FabRx Company Information, Head Office, Market Area and Industry Position
Table 55. FabRx 3D Printing Pharmaceuticals Models, Specifications and Application
Table 56. FabRx 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. FabRx Company Profile and Main Business
Table 58. FabRx Recent Developments
Table 59. Multiply Labs Company Information, Head Office, Market Area and Industry Position
Table 60. Multiply Labs 3D Printing Pharmaceuticals Models, Specifications and Application
Table 61. Multiply Labs 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Multiply Labs Company Profile and Main Business
Table 63. Multiply Labs Recent Developments
Table 64. DiHeSys Company Information, Head Office, Market Area and Industry Position
Table 65. DiHeSys 3D Printing Pharmaceuticals Models, Specifications and Application
Table 66. DiHeSys 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. DiHeSys Company Profile and Main Business
Table 68. DiHeSys Recent Developments
Table 69. Merck Company Information, Head Office, Market Area and Industry Position
Table 70. Merck 3D Printing Pharmaceuticals Models, Specifications and Application
Table 71. Merck 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Merck Company Profile and Main Business
Table 73. Merck Recent Developments
Table 74. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 75. Merck KGaA 3D Printing Pharmaceuticals Models, Specifications and Application
Table 76. Merck KGaA 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Merck KGaA Company Profile and Main Business
Table 78. Merck KGaA Recent Developments
Table 79. TNO Company Information, Head Office, Market Area and Industry Position
Table 80. TNO 3D Printing Pharmaceuticals Models, Specifications and Application
Table 81. TNO 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. TNO Company Profile and Main Business
Table 83. TNO Recent Developments
Table 84. Therics Company Information, Head Office, Market Area and Industry Position
Table 85. Therics 3D Printing Pharmaceuticals Models, Specifications and Application
Table 86. Therics 3D Printing Pharmaceuticals Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Therics Company Profile and Main Business
Table 88. Therics Recent Developments
List of Figure
Figure 1. 3D Printing Pharmaceuticals Picture
Figure 2. By Revenue, Global 3D Printing Pharmaceuticals Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global 3D Printing Pharmaceuticals Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global 3D Printing Pharmaceuticals Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China 3D Printing Pharmaceuticals Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China 3D Printing Pharmaceuticals Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China 3D Printing Pharmaceuticals Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China 3D Printing Pharmaceuticals Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China 3D Printing Pharmaceuticals Share of Global Market, 2018-2029
Figure 10. Global 3D Printing Pharmaceuticals Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global 3D Printing Pharmaceuticals Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China 3D Printing Pharmaceuticals Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China 3D Printing Pharmaceuticals Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China 3D Printing Pharmaceuticals Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of 3D Printing Pharmaceuticals Domestic VS Export, 2022
Figure 16. Global 3D Printing Pharmaceuticals Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global 3D Printing Pharmaceuticals Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global 3D Printing Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
Figure 19. 3D Printing Pharmaceuticals Industry Chain
Figure 20. 3D Printing Pharmaceuticals Procurement Model
Figure 21. 3D Printing Pharmaceuticals Sales Model
Figure 22. 3D Printing Pharmaceuticals Sales Channels, Direct Sales and Distribution
Figure 23. FDM
Figure 24. SLS
Figure 25. PB
Figure 26. SLA
Figure 27. SSE
Figure 28. DPE
Figure 29. DOD
Figure 30. MDD
Figure 31. MED
Figure 32. By Type, Global 3D Printing Pharmaceuticals Revenue, 2018-2029, US$ Million
Figure 33. By Type, Global 3D Printing Pharmaceuticals Revenue Market Share, 2018-2029
Figure 34. By Type, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 35. By Type, Global 3D Printing Pharmaceuticals Sales Volume Market Share, 2018-2029
Figure 36. By Type, Global 3D Printing Pharmaceuticals Price, 2018-2029, (US$/Unit)
Figure 37. Personalized Pharmacy
Figure 38. Nutrients
Figure 39. By Application, Global 3D Printing Pharmaceuticals Revenue, 2018-2029, US$ Million
Figure 40. By Application, Global 3D Printing Pharmaceuticals Revenue Market Share, 2018-2029
Figure 41. By Application, Global 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 42. By Application, Global 3D Printing Pharmaceuticals Sales Volume Market Share, 2018-2029
Figure 43. By Application, Global 3D Printing Pharmaceuticals Price, 2018-2029, (US$/Unit)
Figure 44. By Region, Global 3D Printing Pharmaceuticals Revenue Market Share, 2018-2029
Figure 45. By Region, Global 3D Printing Pharmaceuticals Sales Volume Market Share, 2018-2029
Figure 46. North America 3D Printing Pharmaceuticals Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, North America 3D Printing Pharmaceuticals Revenue Market Share, 2022
Figure 48. Europe 3D Printing Pharmaceuticals Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, Europe 3D Printing Pharmaceuticals Revenue Market Share, 2022
Figure 50. Asia Pacific 3D Printing Pharmaceuticals Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country/Region, Asia Pacific 3D Printing Pharmaceuticals Revenue Market Share, 2022
Figure 52. South America 3D Printing Pharmaceuticals Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. By Country, South America 3D Printing Pharmaceuticals Revenue Market Share, 2022
Figure 54. Middle East & Africa 3D Printing Pharmaceuticals Revenue & Forecasts, 2018-2029, US$ Million
Figure 55. U.S. 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, U.S. 3D Printing Pharmaceuticals Market Share, 2022
Figure 57. By Type, U.S. 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, U.S. 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 59. Europe 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, Europe 3D Printing Pharmaceuticals Market Share, 2022
Figure 61. By Type, Europe 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, Europe 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 63. China 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, China 3D Printing Pharmaceuticals Market Share, 2022
Figure 65. By Type, China 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, China 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 67. Japan 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, Japan 3D Printing Pharmaceuticals Market Share, 2022
Figure 69. By Type, Japan 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, Japan 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 71. South Korea 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, South Korea 3D Printing Pharmaceuticals Market Share, 2022
Figure 73. By Type, South Korea 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, South Korea 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 75. Southeast Asia 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, Southeast Asia 3D Printing Pharmaceuticals Market Share, 2022
Figure 77. By Type, Southeast Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, Southeast Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 79. India 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, India 3D Printing Pharmaceuticals Market Share, 2022
Figure 81. By Type, India 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, India 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 83. Middle East & Asia 3D Printing Pharmaceuticals Sales Volume, 2018-2029, (K Units)
Figure 84. By Company, Middle East & Asia 3D Printing Pharmaceuticals Market Share, 2022
Figure 85. By Type, Middle East & Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 86. By Application, Middle East & Asia 3D Printing Pharmaceuticals Sales Volume Market Share, 2022 VS 2029
Figure 87. Research Methodology
Figure 88. Breakdown of Primary Interviews
Figure 89. Bottom-up Approaches
Figure 90. Top-down Approaches
Research Methodology:
Global 3D Printing Pharmaceuticals Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|